Guardian Financial Partners’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1
Closed -$1K 42
2022
Q3
$1K Hold
1
﹤0.01% 33
2022
Q2
$3K Hold
1
﹤0.01% 39
2022
Q1
$3K Hold
1
﹤0.01% 38
2021
Q4
$17K Buy
+1
New +$23.8K 0.02% 38

Other funds holding VTAK

Guardian Financial Partners's VTAK Position: Q4 2022 in Review

Guardian Financial Partners sold out of Catheter Precision (VTAK) in Q4 2022, closing a stake of 1 share — an estimated $1K sold.

Guardian Financial Partners first reported a position in VTAK in Q4 2021 and held it in 4 quarters. The position peaked at $17K in Q4 2021. 9 funds tracked by Wall St. Rank hold VTAK as of Q4 2022.

  • Guardian Financial Partners reported no remaining Catheter Precision position as of Q4 2022 after selling out during the quarter.
  • Guardian Financial Partners sold 1 Catheter Precision share in Q4 2022, an estimated $1K.
  • Guardian Financial Partners first reported a position in Catheter Precision in Q4 2021 and held it in 4 quarters.
  • Guardian Financial Partners's Catheter Precision position peaked at $17K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Catheter Precision as of Q4 2022.

Based on Guardian Financial Partners's 13F filing for Q4 2022, filed 18 Jan 2023.